Our current study showed, that besides leptin and fibronectin, also plasma UCHL1 could be a promising high-sensitive potential biomarker of relapsing–remitting MS, as it was the most useful in differentiating RRMS patients from healthy individuals. This evidence concerns the gene UCHL1 and disease recurrence.